Cancer Network: Survival Advantage Demonstrated With Higher-Dose Rhenium-186 Nanoliposome in Recurrent Glioma Posted on September 12, 2022 at 11:15 am.Shared by contributor Andrew Brenner, MD, PhD, Medicine/Mays Cancer Center, is quoted in this article. Read More Share This Article!
